AGIO

NASDAQ · Biotechnology

Agios Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$33.54

+0.47 (+1.42%)

As of Sep 21, 2:01 PM ET ·

AGIO News1 articles

Agios Pharmaceuticals Jumps on FDA Priority Review for Sickle Cell Drug

Agios Pharmaceuticals shares jumped 14.9% after the FDA accepted its mitapivat application for sickle cell disease with Priority Review, setting a Nov. 1 PDUFA date.